Receptor Comparison# Weight Loss Efficacy# Retatrutide Phase 2 Results# The Phase 2 obesity trial (Jastreboff et al., NEJM 2023
Stories of individuals losing substantial amounts of weight have received widespread attention on social media, television, and in magazines
You've only got one liver, so do your best to treat it kindly
Janus kinase inhibitors (JAK inhibitors or JAKis), a class of immunomodulatory drugs, are used in the treatment of inflammatory conditions such as rheumatoid arthritis, atopic dermatitis, psoriasis, systemic lupus erythematosus, and myelodysplastic syndromes
Obesity increases their risk for conditions such as heart disease, cancer and high blood pressure
I.Miller-WingA